These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Interferon-alpha and 3'-azido-3'-deoxythymidine are highly synergistic in mice and prevent viremia after acute retrovirus exposure. Ruprecht RM; Chou TC; Chipty F; Sosa MG; Mullaney S; O'Brien L; Rosas D J Acquir Immune Defic Syndr (1988); 1990; 3(6):591-600. PubMed ID: 2159992 [TBL] [Abstract][Full Text] [Related]
3. Antiviral efficacy of Imexon in the Rauscher murine retrovirus AIDS model. Chirigos MA; Ussery MA; Rankin JT; Herrmann D; Bicker U; Black PL Immunopharmacol Immunotoxicol; 1990; 12(1):1-21. PubMed ID: 1693633 [No Abstract] [Full Text] [Related]
4. Murine models for evaluating antiretroviral therapy. Ruprecht RM; Bernard LD; Gama Sosa MA; Sosa MA; Fazely F; Koch J; Sharma PL; Mullaney S Cancer Res; 1990 Sep; 50(17 Suppl):5618S-5627S. PubMed ID: 2167158 [TBL] [Abstract][Full Text] [Related]
5. Chemoprevention of retroviral infection: success is determined by virus inoculum strength and cellular immunity. Ruprecht RM; Bronson R DNA Cell Biol; 1994 Jan; 13(1):59-66. PubMed ID: 8286040 [TBL] [Abstract][Full Text] [Related]
6. Vaccination with a live retrovirus: the nature of the protective immune response. Ruprecht RM; Mullaney S; Bernard LD; Gama Sosa MA; Hom RC; Finberg RW Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5558-62. PubMed ID: 2371289 [TBL] [Abstract][Full Text] [Related]
7. Feline leukemia virus-induced immunodeficiency syndrome in cats as a model for evaluation of antiretroviral therapy. Hoover EA; Zeidner NS; Perigo NA; Quackenbush SL; Strobel JD; Hill DL; Mullins JI Intervirology; 1989; 30 Suppl 1():12-25. PubMed ID: 2540109 [TBL] [Abstract][Full Text] [Related]
8. Suppression of retroviral propagation and disease by suramin in murine systems. Ruprecht RM; Rossoni LD; Haseltine WA; Broder S Proc Natl Acad Sci U S A; 1985 Nov; 82(22):7733-7. PubMed ID: 2415971 [TBL] [Abstract][Full Text] [Related]
9. Effects of SKF 108922, an HIV-1 protease inhibitor, on retrovirus replication in mice. Black Pl; Ussery MA; Barney S; Wittrock R; DeMarsh P; Dreyer GB; Petteway SR; DalMonte P; Baldoni J; Lambert D Antiviral Res; 1996 Mar; 29(2-3):175-86. PubMed ID: 8739597 [TBL] [Abstract][Full Text] [Related]
10. Alteration of cytokine levels in murine retrovirus infection: modulation by combination therapy. Bowden R; Tate SM; Soto S; Specter S Int J Immunopharmacol; 1999 Dec; 21(12):815-27. PubMed ID: 10606002 [TBL] [Abstract][Full Text] [Related]
11. New lipophilic alkyl/acyl dinucleoside phosphates as derivatives of 3'-azido-3'-deoxythymidine: inhibition of HIV-1 replication in vitro and antiviral activity against Rauscher leukemia virus infected mice with delayed treatment regimens. Schwendener RA; Gowland P; Horber DH; Zahner R; Schertler A; Schott H Antiviral Res; 1994 May; 24(1):79-93. PubMed ID: 7944315 [TBL] [Abstract][Full Text] [Related]
12. Bone marrow transplantation therapy using resistant donors for retrovirus-induced leukaemia in mice. Iwai H; Day NK; Hamada N; Inaba MM; Ikehara S; Good RA Clin Exp Immunol; 1994 Jan; 95(1):135-40. PubMed ID: 8287597 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo enhancement of ddI activity against Rauscher murine leukemia virus by ribavirin. Allen LB; Quenelle DC; Westbrook L; Taylor BA; Prichard MN; Brazier AD; Hollingshead MG; Shannon WM Antiviral Res; 1995 Jun; 27(3):317-23. PubMed ID: 8540752 [TBL] [Abstract][Full Text] [Related]
14. Imexon and biological response modifiers in murine models of AIDS. Chirigos MA; Ussery MA; Black PL Int J Immunopharmacol; 1991; 13 Suppl 1():33-41. PubMed ID: 1823906 [TBL] [Abstract][Full Text] [Related]
16. Methionine enkephalin combined with AZT therapy reduce murine retrovirus-induced disease. Specter S; Plotnikoff N; Bradley WG; Goodfellow D Int J Immunopharmacol; 1994 Nov; 16(11):911-7. PubMed ID: 7868296 [TBL] [Abstract][Full Text] [Related]
17. Antileukemic activity of Viva-Natural, a dietary seaweed extract, on Rauscher murine leukemia in comparison with anti-HIV agents, azidothymidine, dextran sulfate and pentosan polysulfate. Furusawa E; Furusawa S; Chou SC Cancer Lett; 1991 Mar; 56(3):197-205. PubMed ID: 1708693 [TBL] [Abstract][Full Text] [Related]
18. Modulation of fas/fasL in a murine retroviral infection by AZT and methionine enkephalin. Bowden R; Soto S; Specter S Adv Exp Med Biol; 2001; 493():143-52. PubMed ID: 11727760 [No Abstract] [Full Text] [Related]
19. Optimization of the reverse transcriptase assay for the detection of viral burden in mice infected with Rauscher murine leukemia virus. White EL; Westbrook L; Hollingshead MG; Shannon WM J Virol Methods; 1996 Oct; 62(1):63-70. PubMed ID: 8910649 [TBL] [Abstract][Full Text] [Related]
20. Combination of inhibitors of lymphocyte activation (hydroxyurea, trimidox, and didox) and reverse transcriptase (didanosine) suppresses development of murine retrovirus-induced lymphoproliferative disease. Mayhew CN; Sumpter R; Inayat M; Cibull M; Phillips JD; Elford HL; Gallicchio VS Antiviral Res; 2005 Jan; 65(1):13-22. PubMed ID: 15652967 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]